This study was conducted to partially characterize and identify the purity of two major outer membrane proteins (OMPs) (with molecular weights of 32,000 and 35,000 [32K and 35K, respectively]) of Pasteurella haemolytica. The 35K and 32K major OMPs, designated Pasteurella outer membrane proteins A and B (PomA and PomB, respectively), were extracted from P. haemolytica by solubilization in N-octyl polyoxyl ethylene. The P. haemolytica strain used was a mutant serotype A1 from which the genes expressing the 30-kDa lipoproteins had been deleted. PomA and PomB were separated and partially purified by anion-exchange chromatography. PomA but not PomB was heat modifiable. The N-terminal amino acid sequences of the two proteins were determined and compared with reported sequences of other known proteins. PomA had significant N-terminal sequence homology with the OmpA protein of Escherichia coli and related proteins from other gram-negative bacteria. Moreover, polyclonal antiserum raised against the E. coli OmpA protein reacted with this protein.
Bovine pneumonic pasteurellosis, also known as shipping fever pneumonia, is the most common cause of beef cattle losses in North America (55) . Pasteurella haemolytica biotype A serotype 1 is the principal etiologic agent of bovine pneumonic pasteurellosis (17, 18) .
Much effort has been expended towards development of more efficacious vaccines for the prevention of bovine pneumonic pasteurellosis (11, 31) . To develop such vaccines, investigators have attempted to better understand P. haemolytica virulence factors and the host immune response. Recently, Morton et al. (29) demonstrated that cattle vaccinated with P. haemolytica A1 outer membranes had enhanced resistance to experimental challenge with the homologous serotype. In a previous study, high antibody responses to P. haemolytica saline-extracted proteins with molecular masses of 16, 30, 40, 42 , and 86 kDa consistently correlated with resistance to challenge with virulent P. haemolytica (32) . It was proposed that the protein with a molecular mass of approximately 30 kDa is a major outer membrane protein (OMP) and that this protein may be important in inducing immunity to P. haemolytica (13) . The tandemly arranged genes for three P. haemolytica membrane lipoproteins, which are approximately 28 to 30 kDa and similar to an Escherichia coli 28-kDa lipoprotein, were recently cloned and sequenced (13, 35) . Serum antibodies to two of the lipoproteins correlated with resistance to experimental challenge (13, 14) .
Our preliminary studies suggested that another major P. haemolytica OMP was similar to the E. coli OmpA protein. The outer membranes of numerous species of gram-negative bacteria, both enteric and nonenteric, contain major heat-modifiable proteins structurally similar to OmpA (4) . Those bacteria include Actinobacillus actinomycetemcomitans (52) , Haemophilus somnus (48) , Haemophilus influenzae (33, 50) , Haemophilus ducreyi (47) , Salmonella typhimurium (19) , Shigella dysenteriae (5), Neisseria gonorrhoeae (22) , Pseudomonas aeruginosa (23, 54) , and Serratia marcescens (6) . The OmpA protein is important in maintaining integrity of the E. coli outer membrane (46) , and it stimulates a strong antibody response (41) . Also, OmpA may play an important role in virulence, because an OmpA-deficient mutant of E. coli K-1 had reduced virulence in an infant rat model of bacteremia (51) . Antibodies against OmpA and several OmpA family proteins are bactericidal, opsonic, or protective (24, 25, 28, 37) . In contrast, antibodies to the OmpA homolog of N. gonorrhoeae inhibit serum bactericidal activity (42) .
The aim of the present study was to purify and characterize two P. haemolytica OMPs that comigrate with molecular weights of approximately 30,000 (30K) during sodium dodecyl sulfate-12% polyacrylamide gel electrophoresis (SDS-12% PAGE) but separate as bands of 35K and 32K on SDS-18% PAGE gels. These proteins were characterized by determination of their N-terminal amino acid sequences and evaluation of antigenicity by Western immunoblotting with sera from vaccinated and subsequently experimentally challenged cattle.
MATERIALS AND METHODS
Bacteria and culture conditions. P. haemolytica 89010807N (lpp) is a mutant A1 serotype developed by one of us (G.L.M.) (36) . The genes for expression of three 30K lipoproteins have been detected. This mutant was selected because the 30K lipoproteins are in outer and inner membranes and could interfere with purification or detection of OMPs under study. The bacterium was grown for 16 to 18 h on brain heart infusion (BHI) agar (Difco Laboratories, Detroit, Mich.) containing ampicillin (10 g/ml) and nalidixic acid (20 g/ml) to maintain selective pressure. The culture was visually inspected for purity. Several colonies were inoculated into 100 ml of BHI broth containing ampicillin (10 g/ml) and nalidixic acid (20 g/ml) and incubated at 37ЊC at 80 rpm on a rotary shaker overnight. Subsequently, 100 ml of the overnight culture was inoculated into 2 liters of BHI broth containing ampicillin (10 g/ml) and nalidixic acid (20 g/ml) and incubated at 37ЊC for 16 to 18 h on a rotary shaker at 80 rpm. Bacteria were harvested by centrifugation at 8,000 ϫ g for 10 min at 4ЊC, resuspended and washed twice with sterile phosphate-buffered saline (PBS; pH 7.2), and centrifuged as described above to obtain pellets. Cell pellets were stored frozen at Ϫ20ЊC for subsequent OMP extraction.
P. haemolytica envelope preparation. Each bacterial pellet from 2 liters of BHI broth was resuspended in 20 ml of solution containing 10 mM Na 2 HPO 4 , 5 mM MgSO 4 (pH 7.4), DNase (50 g/ml; Sigma Chemical Co., St. Louis, Mo.), and RNase (50 g/ml; Sigma Chemical Co.) and sonicated on ice (Branson Sonifier Cell Disruptor; VWR Scientific, Danbury, Conn.) five times for 30 s each (continuously) with 30-s intervals with a double-step microtip probe (50 W) to lyse the cells. The bacterial suspension was centrifuged at 950 ϫ g for 10 min, and the supernatant was collected. The supernatant was then centrifuged at 205,800 ϫ g for 1 h at 4ЊC with a 55.2 Ti rotor (Beckman Ultracentrifuge). The envelope-rich pellet was resuspended in 10 ml of distilled H 2 O, and the protein concentration was determined by bicinchoninic acid protein assay (Pierce Biochemical).
OMP extraction. Two OMPs designated Pasteurella outer membrane protein A (PomA) (upper band) and PomB (lower band) identified by SDS-PAGE were extracted from the envelope by a modification of a previously described n-octyl polyoxyl ethylene (OPOE) (Octyl-POE; Bachem Bioscience Inc., Philadelphia, Pa.) solubilization method (45) . The envelope was resuspended by sonicating three times at a concentration of 10 mg/ml in 10 mM Tris-HCl (pH 8.0)-0.5% OPOE. After centrifugation at 154,000 ϫ g for 1 h at 20ЊC, the supernatant (designated supernatant 1) was collected. The pellet was resuspended by sonication as described above in 10 mM Tris-HCl (pH 8.0)-3% OPOE. This step was repeated twice to obtain supernatants 2 and 3. The resulting pellet was then resuspended in 50 mM Tris-HCl (pH 8.0)-50 mM EDTA-3% OPOE by sonication and centrifuged again as described above. The supernatant was collected (supernatant 4), and the steps were repeated for the remaining pellet to obtain supernatant 5. The resulting pellet was resuspended in 50 mM EDTA-0.4 M NaCl-3% OPOE, sonicated, and centrifuged as described above. Supernatant 6 was collected, and the pellet was resuspended in distilled H 2 O, sonicated, and centrifuged as described above. Both the pellet and the supernatant (supernatant 7) were collected. Outer membranes were also extracted separately in 0.5% sodium N-lauryl sarcosine (Sarkosyl; Sigma Chemical Co.) as previously described (29) .
Anion-exchange purification. Supernatant 4 (which contained PomA and PomB) was prepared for anion-exchange chromatography by equilibrating in 10 mM Tricine buffer (buffer A or binding buffer), pH 8.9, by dialysis. An anionexchange column (Econo-Pac High Q Cartridge; Bio-Rad, Hercules, Calif.) was washed and equilibrated according to the manufacturer's instructions. The sample (1 ml) was applied to the column and washed with 10 ml of buffer A. The column was eluted by a linear gradient of 0.5 to 2 M NaCl in 10 mM Tricine buffer (elution buffer or buffer B), pH 8.9, at a flow rate of 0.5 ml/min. Fractions containing protein peaks were collected, concentrated by ultrafiltration with a PM 10 filter (Amicon Inc., Beverly, Mass.), and dialyzed against 10 mM Tricine buffer, pH 8.9. Proteins were identified in peak fractions by SDS-18% PAGE.
SDS-PAGE. Supernatants and pellets were subjected to SDS-PAGE as described previously (16, 27) . Briefly, the samples were solubilized in Laemmli sample buffer (27) containing 5% ␤-mercaptoethanol and heated to 100ЊC for 2 to 3 min. Samples were loaded onto a 4.5% acrylamide stacking gel overlaying an 18% acrylamide resolving gel (except where stated that a 10% resolving gel was used) and separated by electrophoresis (Mini Protean II Electrophoresis Cell; Bio-Rad, Rockville Centre, N.Y.). Molecular weights of proteins were determined with known standards.
Anti-PomA sera. Antibodies to PomA were produced by immunizing a 4-weekold Holstein calf with gel-purified PomA as described previously (13) . Supernatant 4 was subjected to SDS-PAGE. PomA was identified, excised with a sterile scalpel, and emulsified with an equal volume of Freund's incomplete adjuvant (FIA). The calf was immunized intramuscularly on days 0 and 15. Sera were collected on days 0, 15, 28, and 35.
ELISA. Sera from the calf immunized with PomA and from cattle described below were assayed for antibody responses to supernatant 6 by an enzyme-linked immunosorbent assay (ELISA) (8) . Microtiter plates were coated with supernatant 6 that had been concentrated and dialyzed into coating buffer at a concentration of 50 ng of protein per well. Sera were diluted 1:1,000 and reacted with the antigen. Antibody binding was detected with horseradish peroxidase (HRP)-conjugated affinity-purified rabbit anti-bovine immunoglobulin G (IgG) (PelFreez, Rogers, Ark.). All assays were done in triplicate. Data were reported as mean optical densities at 490 nm (OD 490 ) Ϯ standard deviations.
Western immunoblots. Extracts were subjected to SDS-PAGE, electrophoretically transferred to nitrocellulose membranes as previously described (16) , and probed with calf anti-P. haemolytica PomA serum and rabbit anti-E. coli OmpA serum (the latter was kindly provided by Ulf Henning, Tübingen, Germany) (20, 43) . The antibody complexes were detected by incubating with HRP-conjugated affinity-purified goat anti-rabbit IgG (Pel-Freez) or HRP-conjugated affinitypurified rabbit anti-bovine IgG (Pel-Freez). Serum samples obtained from cattle vaccinated with P. haemolytica (described below) were evaluated on Western immunoblots against PomA and PomB as previously described (13, 14, 31, 40) . Briefly, supernatant 6 containing mostly PomA from OPOE extraction and anion-exchange-purified PomB from supernatant 4 were subjected to SDS-PAGE, transferred to nitrocellulose membranes, and probed with a 1:25 dilution of cattle serum for 2 h. Immune complexes were detected with the HRP-conjugated rabbit anti-bovine IgG (8) . Color reactions were developed with 0.05% 4-chloro-1-naphthol dissolved in 20 ml of ice-cold methanol and 0.05% H 2 O 2 in 100 ml of Tris-buffered saline, pH 7.4.
Heat modifiability. To determine the heat modifiability of proteins, fractions were solubilized in sample buffer at 37 or 100ЊC for 10 min and subjected to SDS-PAGE.
Surface exposure of PomA. To determine surface exposure of proteins, P. haemolytica cells (1 ml) in the mid-logarithmic phase of growth were collected by centrifugation and washed in an equal volume of enzyme buffer (0.08 M Tris-HCl [pH 8.0], 0.1 M CaCl 2 ). Cells were resuspended in 0.25 ml of enzyme buffer, and 50 g of chymotrypsin (Sigma) in 0.005 ml of enzyme buffer was added (40) . Negative controls received an equal volume of enzyme buffer with no enzyme. Cells were incubated on a rotary shaker (120 rpm) for 1 h at 37ЊC, collected by centrifugation, and washed with 1 ml of PBS. For SDS-PAGE, enzyme-treated and control cells at the same concentration based on OD 650 readings were resuspended in 0.05 ml of PBS and 0.05 ml of Laemmli sample buffer and heated at 95ЊC for 5 min before SDS-10% PAGE and Western blot analysis (40) .
N-terminal amino acid sequencing. Supernatant 4 was subjected to SDS-PAGE, electrophoretically transferred to a polyvinylidene difluoride membrane (Bio-Rad, Hercules, Calif.), and stained with Coomassie brilliant blue R-250 (Bio-Rad, Hercules, Calif.). The bands were identified by comparison with molecular weight markers. Strips of membrane containing PomA and PomB were excised and subjected to N-terminal amino acid sequencing (Molecular Biology Resource Facility, University of Oklahoma Health Sciences Center).
Serotype specificity of PomA. To determine the conservation of PomA in different P. haemolytica serotypes, whole-cell lysates of A biotypes (serotypes 1, 2, 5, 6, 7, 8, 9, 10, 12, 13, and 14) and strain 89010807N (lpp) were solubilized in sample buffer at 100ЊC for 2 min and subjected to SDS-PAGE. Proteins were transferred to nitrocellulose membranes and probed with a dilution of 1:200 calf anti-PomA serum to detect OmpA family protein bands.
Planar bilayer methods. Planar bilayers were made from 1.5% oxidized cholesterol (kindly provided by R. Benz, Würzburg, Germany) in n-decane. An applied voltage of 50 mV and a bathing solution of 1 M KCl were employed. The PomA protein was added to the bathing solution on one side of the bilayer to a final concentration of 60 ng/ml. All other experimental conditions were as previously described for outer membrane porin protein F of P. aeruginosa (OprF) (53) . Controls were nonporin and standard porin protein preparations from E. coli and P. aeruginosa.
Antibody responses in cattle. Antibody responses to partially purified PomA (supernatant 6) were quantified by ELISA. Antibody responses to anion-exchange-purified PomA and PomB were quantified on Western immunoblots by using densitometry as used previously in our laboratories (8, 13, 14, 32, 40) . Serum samples were obtained from 20 weanling cattle that had been previously experimentally vaccinated and challenged with P. haemolytica A1 (9, 10, 12, 39). Cattle were equally divided among four groups and vaccinated twice subcutaneously (days 0 and 7) with either PBS, formalin-killed P. haemolytica with aluminum hydroxide (bacterin-AlOH), formalin-killed P. haemolytica with FIA (bacterin-FIA), or 10 9 CFU of live P. haemolytica. On day 21, cattle were challenged transthoracically in the caudal lung lobes with 5 ϫ 10 9 CFU of P. haemolytica (39) . Four days later, cattle were euthanatized, and lung lesion scores ranging from 0 to 20 were assigned based on the criteria of intensity and spread of lesion (the higher the score was, the more intense the lesion was) (39) .
Reactivity of day 0 and day 21 sera to PomA and PomB on Western immunoblots was quantified by measuring the intensity of the bands with a onedimensional-gel scanner (Protein Database Inc., Huntington Station, N.Y.). The blots were scanned, and the OD (trace OD times millimeters) were determined as indirect measurements of the antibody responses (8, 13, 14, 32, 40) .
Statistical analysis. Mean values for trace OD times millimeters (mean OD values) for PomA and PomB were compared among the vaccine groups by two-sample t tests (2). Within groups, mean OD values were compared by paired t tests. Linear regression analysis was used to correlate antibody responses as measured by ELISA or Western blot-densitometry and lesion scores (31).
PomA) was prominent, and the lower band (designated PomB) was much less so. The apparent molecular weight of PomA and PomB varied with the percentage of the resolving gels used. We observed that PomA and PomB comigrated at approximately 30K on 12% gels. To electrophoretically separate these protein bands, we used SDS-18% PAGE. This resolved these proteins into two bands corresponding to molecular weights of 35K (PomA) and 32K (PomB) (Fig. 1) .
To test whether the two protein bands represented different proteins or were different forms of the same protein, we determined the N-terminal amino acid sequences. This analysis suggested that the two bands represented two different proteins. The N-terminal amino acid sequence of PomA is shown in Table 1 . Comparison of this sequence with published sequences by using the BLAST network service (1) revealed that PomA had 60% identity with the N-terminal amino acid sequence of the E. coli OmpA protein (4) and varied from 60 to 100% identity with related proteins from several other gramnegative bacteria (Table 1) (1, 5, 6, 19, 33, 34, 47, 52) .
Further evidence that PomA was related to E. coli OmpA was obtained by Western immunoblot analysis (Fig. 2) . Rabbit antiserum against E. coli OmpA reacted strongly with PomA of P. haemolytica. Calf anti-P. haemolytica PomA sera also reacted with the same band. The molecular weight of P. haemolytica PomB was 32K. The N-terminal amino acid sequence was ADTIG FVDPSYVLENHPVLLDAS. A search of protein sequence databases with the BLAST network service (1) failed to find any substantial homology with other known bacterial proteins.
Heat modifiability of PomA. In undialyzed supernatant 4 or supernatant 6 samples evaluated by SDS-PAGE, PomA had an apparent molecular weight of 35K after incubation at 37 and 100ЊC. However, SDS-PAGE analysis of PomA present in dialyzed (against deionized water) supernatant 4 fraction and incubated in sample buffer at 37ЊC demonstrated two antigenic bands, one with a molecular weight of 35K and the other at 40K (Fig. 2) . In contrast, solubilization of dialyzed PomA at 100ЊC for 10 min resulted in an apparent molecular weight of 40K. On Western immunoblots, both 35K and 40K bands were identified with anti-E. coli OmpA and calf anti-P. haemolytica PomA sera, indicating that they represent a single protein. molecular weight at both at 37 and 100ЊC in dialyzed and undialyzed preparations (data not shown). Surface exposure of PomA. Because many of the properties of PomA were similar to those of E. coli OmpA, we wanted to know whether PomA was surface exposed like other members of the OmpA family (7, 21, 38) . To determine the presence of surface-exposed regions of PomA, intact P. haemolytica cells were treated with chymotrypsin. Whole-cell lysates of protease-treated cells were examined by Western immunoblot analysis with anti-E. coli OmpA serum (Fig. 3) . Anti-OmpA serum identified two bands, one at approximately 30K and one at 40K, by SDS-10% PAGE; the latter most likely was the heat-modified form. Comparison of protease-treated and untreated lysates indicated that chymotrypsin treatment resulted in a loss of immunoreactivity with anti-E. coli OmpA sera (39) . This indicated surface exposure of PomA.
Serotype specificity of PomA. On Western immunoblots (Fig. 4) of whole-cell lysates of different serotypes of P. haemolytica biotype A, one to two bands were identified with bovine anti-P. haemolytica PomA sera. For serotypes 1 to 8 and 11, 13, and 14, the positive bands corresponded to unmodified (35K) forms of PomA. For serotype 12, a faintly staining band was identified at 35K and an intensely staining band was identified at 37K. Our strain of serotype 9 has a different OMP pattern, and several bands stained positively with anti-PomA serum. This is consistent with the recently published data of Morton et al. (30) , which showed that the outer membrane profile of this serotype 9 strain is different from those of other serotypes of P. haemolytica biotype A. These results suggest that all P. haemolytica biotype A serotypes contain OmpA family proteins.
Anion-exchange purification. Further OPOE extraction of supernatant 4 yielded partial purification of PomA. PomB was greatly reduced in those extractions (supernatants 5 and 6). To determine if PomA and PomB could be separated and each partially purified from supernatant 4, we used anion-exchange chromatography. All proteins in supernatant 4 bound to the column (pH 8.9). Proteins were eluted with a linear gradient of elution buffer resulting in two protein peaks (Fig. 5) . These proteins were identified in concentrated and dialyzed peak fractions by SDS-PAGE (Fig. 6 ). PomB eluted with a salt concentration gradient of 0.62 to 0.66 M NaCl, and PomA eluted with a salt concentration gradient of 1.98 to 2.0 M NaCl. Thus, it was possible to separate and partially purify PomA and PomB effectively by anion-exchange chromatography. N-terminal sequencing confirmed the separation of the two proteins.
Porin activity of PomA. Previous data have indicated that other members of the OmpA superfamily, including OprF (53) and OmpA itself (44) , predominantly form small channels of around 300-pS conductance in 1 M KCl. Similar studies with PomA revealed that this protein also formed small ion-permeable channels with a single-channel conductance of 105 Ϯ 34 pS in 1 M KCl. Many of these channels had quite short half- lives of around 10 s or less, and at higher concentrations of protein in the chamber, events as large as 600 pS were observed, possibly due to aggregation or coincident insertion of channels into the bilayer. Thus, these data revealed that PomA, like other members of the OmpA superfamily, had porin activity.
Antibody responses of cattle. To evaluate the antigenicity of PomA and PomB for cattle, antibody responses (OD values) to supernatant 6, purified PomA, and purified PomB were determined in sera from cattle in four vaccinated groups (8, 13, 14, 32, 40) . There were significant differences between the mean lesion scores for PBS-vaccinated versus live-organism-vaccinated (P Ͻ 0.05), PBS-vaccinated versus bacterin-FIA-vaccinated (P Ͻ 0.05), and PBS-vaccinated versus bacterin-AlOHvaccinated (P Ͻ 0.05) cattle ( Table 2) . Vaccination of cattle with bacterin-FIA or live bacteria resulted in significant (P Ͻ 0.05) increases in antibody responses to supernatant 6 as measured by ELISA. Antibody responses did not significantly increase for the PBS and bacterin-AlOH groups. Antibody responses on day 21 were significantly greater (P Ͻ 0.05) for the groups vaccinated with bacterin-FIA and live bacteria compared to either the bacterin-AlOH or PBS group.
Antibody responses to purified PomA, as measured by Western blot-densitometry, significantly increased (P Ͻ 0.05) between days 0 and 21 for all groups. There were no significant differences (P Ͼ 0.05) between mean antibody responses against purified PomA (day 21) among P. haemolytica-vaccinated groups and PBS control groups. The antibody response of vaccinates receiving live bacteria to purified PomB was significantly (P Ͻ 0.05) greater on day 21 than on day 0. Significant differences (P Ͻ 0.05) were seen between antibody responses to PomB (day 21) for groups receiving PBS and live bacteria. There were no significant differences (P Ͼ 0.05) in antibody responses to PomB between PBS-and bacterinAlOH-vaccinated or PBS-and bacterin-FIA-vaccinated groups.
Regression analysis indicated a strong correlation (r ϭ Ϫ0.645; P Ͻ 0.002) between high antibody responses to supernatant 6 and resistance to challenge. The correlations between high antibody responses to purified PomA and to purified PomB and resistance to challenge were less significant than those to supernatant 6 (r ϭ Ϫ0.439 and r ϭ Ϫ0.458, respectively; P Ͻ 0.05).
DISCUSSION
In this study, we partially purified and characterized two membrane proteins of P. haemolytica, termed PomA and PomB (35K and 32K, respectively), which eluted in fractions 4, 5, and 6 of an OPOE OMP extraction. Previous studies (35) identified three lipoproteins (28 to 30 kDa) that are in the Sarkosyl-soluble and -insoluble fractions of P. haemolytica A1. To prevent interference of these proteins in identification and characterization of PomA and PomB, we used P. haemolytica lipoprotein-deficient mutant 89010807N (lpp) (36) , which no longer produces these three lipoproteins. Even though supernatant 6 yielded partially purified PomA, it also had relatively small quantities of PomB. Hence, for future studies of the OmpA family protein of P. haemolytica, anion-exchange chromatography could be used to separate and purify PomA and PomB from supernatant 4. VOL. 65, 1997 OmpA PROTEINS OF P. HAEMOLYTICA
The N-terminal sequence of PomA and immunoblot analysis data indicate that this protein has substantial homology and shares epitopes with E. coli OmpA. Comparisons of the Nterminal amino acid sequence of PomA with sequences from OmpA family proteins from seven other bacterial species indicated that PomA is probably a member of the OmpA family of proteins. These are major bacterial OMPs and are conserved among many gram-negative bacteria. In addition, immunoreactive OmpA family proteins were found in each of the P. haemolytica biotype A serotypes, indicating conservation among P. haemolytica serotypes.
The N-terminal amino acid sequences for P. haemolytica PomA and PomB were different. We compared the sequence of PomB with other portions of the published sequence of E. coli OmpA and found no homology. Therefore, it is unlikely that PomB is a cleaved portion of PomA or a member of the OmpA family of proteins.
The outer membranes of several strains of E. coli, other enteric bacteria, and a variety of nonenteric gram-negative bacteria contain major heat-modifiable proteins similar to OmpA of E. coli (4) . Several heat-modifiable proteins have been identified in P. haemolytica (26) . In supernatant 4 dialyzed against deionized water, PomA appeared in two forms, 35K and 40K, when incubated at 37ЊC. Like several other OmpA family proteins, PomA was heat modifiable such that incubation for 10 min at 100ЊC resulted in only a 40K form being present. PomA, however, migrated at 35K and was not heat modifiable unless the supernatant was dialyzed against deionized water. This behavior is most likely due to removal of components that stabilize the protein in its heat-unmodified form. Chymotrypsin treatment of P. haemolytica indicated that PomA is surface exposed like E. coli OmpA. Functional characterization of PomA revealed that it had porin activity. All these properties of PomA support its inclusion in the OmpA family of proteins.
OmpA proteins confer stability to outer membranes (46), serve as receptors for certain bacteriophages (15, 49) , and stabilize mating aggregates formed during F pilus-mediated conjugation (49) . A recent study demonstrated that OmpA is a factor in determining resistance to complement-mediated serum killing of a virulent strain of E. coli K-1 (51) . However, the finding that antibodies to the OmpA family protein in N. gonorrhoeae inhibit serum bactericidal activity indicates that antibodies to this group of proteins could be detrimental to host defenses (42) . To determine the potential role of P. haemolytica PomA and PomB in immunity, antibody responses to supernatant 6, which contains mainly PomA, and to purified PomA and PomB were determined in sera from cattle that had been experimentally vaccinated with live or killed P. haemolytica. In an ELISA with supernatant 6 (predominately PomA), there were significant increases in antibody response in all P. haemolytica vaccinates. Antibody responses in control cattle remained unchanged. As shown by Western blotting-densitometry, antibody responses to purified PomA increased for P. haemolytica and for PBS vaccinates. In addition, the correlation between high antibody responses and resistance to challenge was markedly less for the antibodies measured by Western blot-densitometry than for those measured by ELISA. The reasons for these findings are not known with surety. During the course of cattle experiments, one frequently finds an increase in antibodies to P. haemolytica due to inhalation of P. haemolytica endogenous to the nasal flora. It is unlikely, however, that the increase in antibodies to purified PomA detected in the PBS vaccinates was due to antibodies to endogenous P. haemolytica, because the responses to PomB and to supernatant 6 did not increase in that group of cattle.
Other gram-negative bacteria are part of the normal nasal and intestinal flora and could have stimulated antibodies to OmpA family proteins that cross-reacted with PomA. Those could have been detected in sera from the PBS vaccinates. This scenario is possible; however, we found that Western blots against E. coli whole-cell lysates using sera from PBS vaccinates had similar reactions to proteins in the 30K to 40K range for the day 21 and day 0 sera (data not shown). Therefore, it is unlikely that the antibody responses to purified PomA that were detected by Western blotting-densitometry are cross-reactive antibodies to E. coli OmpA.
The results of this experiment raise questions about the potential immunologic significance of antibody responses to PomA. By Western blot-densitometry, the PBS-vaccinated controls had higher quantities of antibodies to PomA but were more susceptible to challenge than the bacterin-AlOH group. A high antibody response to PomA, as measured with these Western blots, was not a good indicator of any potential protection against experimental P. haemolytica challenge. However, the potential for cattle to develop antibodies to OmpA family proteins, other than from E. coli, and for those antibodies to cross-react with PomA and be detected in Western blots must still be considered. Therefore, characterization of the functional immune response to PomA is needed to determine if PomA has immunologic significance in bovine pneumonic pasteurellosis. 
